Q4 was overall strong with both sales and earnings topping our expectations ahead of the quarter (no consensus). SyntheticMR mentions that the recently signed licensing and distribution agreements with Philips and Siemens are already bearing fruit with both of them generating orders in Q4. The shares were trading weakly ahead of the numbers, and this should warrant some relief in our view.
LÄS MER